Susceptibility Pattern of Caspofungin-Coated Gold Nanoparticles Against Clinically Important Candida Species

Susceptibility Pattern of Caspofungin-Coated Gold Nanoparticles Against Clinically Important Candida Species

Purpose: The present study was performed to examine whether caspofungin-coated gold nanoparticles (CAS-AuNPs) may offer the right platform for sensitivity induction in resistant isolates. Methods: A total of 58 archived Candida species were enrolled in the research. The identification of Candida spp...

Full description

Bibliographic Details
Main Authors:	Zahra Salehi, Azam Fattahi, Ensieh Lotfali, Abdolhassan Kazemi, Ali Shakeri-Zadeh, Saman Ahmad Nasrollahi
Format:	Article
Language:	English
Published:	Tabriz University of Medical Sciences 2021-09-01
Series:	Advanced Pharmaceutical Bulletin
Subjects:	candida albicans non- albicans candida cas-aunps conjugate caspofungin
Online Access:	https://apb.tbzmed.ac.ir/PDF/apb-11-693.pdf

Similar Items

Susceptibility to caspofungin is regulated by temperature and is dependent on calcineurin in Candida albicans
by: Lijun Zheng, et al.
Published: (2023-12-01)

Disseminated candidemia refractory to caspofungin therapy in an infant with extremely low birth weight
by: Meng-Ju Li, et al.
Published: (2012-01-01)

Antifungal activity of caspofungin in experimental infective endocarditis caused by Candida albicans
by: Gerardo Becerra Victorio, et al.

Management of a case of Candida albicans endogenous endophthalmitis with intravitreal caspofungin
by: Harshali Manish Yadav, et al.
Published: (2017-01-01)

Proteomic Analysis of Caspofungin-Induced Responses in Planktonic Cells and Biofilms of Candida albicans
by: Peng Li, et al.
Published: (2021-02-01)

Isolation, molecular identification, and antifungal susceptibility profiles of vaginal isolates of Candida species
by: Ali Rezaei-Matehkolaei, et al.
Published: (2017-03-01)

Caspofungin-induced β(1,3)-glucan exposure in Candida albicans is driven by increased chitin levels
by: Andrew S. Wagner, et al.
Published: (2023-08-01)

Biomarkers of caspofungin resistance in Candida albicans isolates: A proteomic approach
by: Giuseppe Buda De Cesare, et al.
Published: (2022-12-01)

The Effects of Holothurin and Caspofungin on the Vaginal Cell Inflammation Parameters of the Rattus norvegicus Strain Post Induction of Candida albicans
by: Handayani S, et al.
Published: (2023-04-01)

Candida spp. with Acquired Echinocandin Resistance, France, 2004–2010
by: Eric Dannaoui, et al.
Published: (2012-01-01)

Oral Candida colonization and anti-fungal susceptibility pattern in patients with hematological malignancy
by: Maryam Talebshoushtari Zadeh, et al.
Published: (2022-09-01)

The efficacy of gaseous ozone against different forms of Candida albicans
by: Mahdis Zargaran, et al.
Published: (2017-06-01)

<i>Candida albicans</i> Strains Adapted to Caspofungin Due to Aneuploidy Become Highly Tolerant under Continued Drug Pressure
by: Farha Husain, et al.
Published: (2022-12-01)

Caspofungin in Recurrent Fluconazole Resistant Candida Esophagitis Treatment
by: Çiğdem EROL, et al.
Published: (2007-09-01)

Epidemiology and antifungal susceptibility of Candida species in a tertiary care hospital, Kolkata, India
by: Partha Bhattacharjee
Published: (2016-06-01)

Isolation, Identification and Antifungal Susceptibility Testing of Candida Species: A Cross-sectional Study from Manipur, India
by: Urvashi Chongtham, et al.
Published: (2022-04-01)

Biliary co-infection by multidrug-resistant Candida glabrata and Candida albicans in a case of pancreatic cancer with cholangitis: A case report and review of literature
by: Amir Sadeghi, et al.
Published: (2024-03-01)

Speciation and Antifungal Susceptibility Testing of Candida isolated from Immunocompromised Patients of a Tertiary Care Centre in Gujarat, India
by: Anita, et al.
Published: (2023-03-01)

Peripheral Candidal Suppurative Thrombophlebitis Successfully Treated with Caspofungin in a Bariatric Surgery Patient
by: Özgür GÜNAL, et al.
Published: (2012-12-01)

Genome-Wide DNA Changes Acquired by <i>Candida albicans</i> Caspofungin-Adapted Mutants
by: Jeffrey Zuber, et al.
Published: (2023-07-01)

Distribution of clinical isolates of Candida spp. and antifungal susceptibility of high biofilm-forming Candida isolates
by: Gulcan Sahal, et al.

Drug susceptibility pattern of candida species isolated from skin of neonates to fluconazole, amphotericin B and caspofungin
by: Soraya Ghorbani, et al.
Published: (2017-07-01)

Enhanced susceptibility of Candida albicans to chlorhexidine under anoxia
by: Andressa Marafon Semprebom, et al.
Published: (2015-12-01)

mSphere of Influence: a Systematic Approach To Dissect Virulence Traits in <named-content content-type="genus-species">Candida albicans</named-content>
by: J. Christian Pérez
Published: (2019-06-01)

Deletion of AIF1 but not of YCA1/MCA1 protects Saccharomyces cerevisiae and Candida albicans cells from caspofungin-induced programmed cell death
by: Christopher Chin, et al.
Published: (2014-01-01)

Efficacy of humanized single large doses of caspofungin on the lethality and fungal tissue burden in a deeply neutropenic murine model against Candida albicans and Candida dubliniensis
by: Prépost E, et al.
Published: (2019-07-01)

Prevalence and antifungal drug resistance of nosocomial Candida species isolated from two university hospitals in Egypt
by: Amira M El-Ganiny, et al.
Published: (2021-03-01)

Identificação de espécies de Candida e susceptibilidade antifúngica in vitro: estudo de 100 pacientes com candidíases superficiais Identification of Candida species and antifungal susceptibility in vitro: a study on 100 patients with superficial candidiasis
by: Elisete I. Crocco, et al.
Published: (2004-12-01)

Candida dubliniensis does not show phospholipase activity: true or false? Candida dubliniensis não evidencia atividade fosfolipásica: verdadeiro ou falso?
by: Liliane Alves Scheid, et al.
Published: (2010-04-01)

Detection of Phospholipase Activity in Candida albicans Isolates
by: Sevtap ARIKAN, et al.
Published: (1998-12-01)

Complicated bilateral fungal emphysematous pyelonephritis in a 55-year-old diabetic female: A case report and review of literature
by: Ensieh lotfali, et al.
Published: (2018-06-01)

A Markerless CRISPR-Mediated System for Genome Editing in Candida auris Reveals a Conserved Role for Cas5 in the Caspofungin Response
by: Craig L. Ennis, et al.
Published: (2021-12-01)

Candida species causing vulvovaginitis among patients in Babcock University Teaching Hospital, Ilishan-Remo, Ogun State: A retrospective cross-sectional study
by: Tinuade Adesola Ajani, et al.
Published: (2024-01-01)

Minimum Inhibitory Concentration of Peganum Harmala Extract Against Candida Species
by: M Baharvand, et al.
Published: (2022-07-01)

In vitro synergistic antifungal activities of caspofungin in combination with fluconazole or voriconazole against Candida species determined by the Etest method
by: Qianting Yang, et al.
Published: (2022-09-01)

A study of Candida albicans and non-albicans Candida species isolated from various clinical samples and their antifungal susceptibility pattern
by: Ratna Shukla, et al.
Published: (2020-01-01)

Evaluation of Diverse Phenotypic Methods for Differenting between Candida dubliniensis and Candida albicans
by: Dayana Camacho, et al.
Published: (2012-01-01)

Vaginal candidosis: the place of butоconazol in pharmacotherapy
by: G S Bogdanova, et al.
Published: (2013-02-01)

Candida species distribution and fluconazole susceptibility of blood isolates at a regional hospital in Passo Fundo, RS, Brazil
by: Maira Giseli C. Silva, et al.
Published: (2015-06-01)

Retrospective analysis on distribution and antifungal susceptibility profile of Candida in clinical samples: a study from Southern India
by: Umamaheshwari S., et al.
Published: (2023-05-01)